Medical Device News Magazine

Shanghai Operation Robot Announces the 1st Robot-assisted Human Clinical Trial of Biliary Stent Placement Surgery

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Shanghai Operation Robot Co., Ltd announced the results of its initial clinical trial of ERCP (Endoscopic retrograde cholangiopancreatography) robot in biliary stent placement surgery. It is the first Robot-assisted human clinical trial of biliary stent placement surgery in the world. The surgery was conducted by Aopeng Medical.

The operation was performed by the team of Professor and Dr. Xiaofeng Zhang, vice president of Hangzhou First People’s Hospital and director of the Center for Digestive Endoscopy. Dr. Zhang operated the robot outside the operating room (without wearing heavy lead), advanced the guidewire and balloon catheter in a precisely controlled manner and successfully completed the entire surgical procedure including the nipple cutter action, balloon stone removal, and accurate placement of bile duct stents.

Dr. Zhang highly values the precision performance of the ERCP robot from Shanghai Operation Robot, and the benefit for physicians in reducing radiation exposure during the surgery. This surgery was live-streamed at the meeting of the 15th Hangzhou International Symposium on Diagnosis and Treatment of Biliary and Pancreatic Diseases. Many experts in the audience watched the whole procedure and considered it a great success for robot-assisted ERCP surgery.

This trial verified the application of surgical robots in the field of natural orifice ERCP surgery and opened a new era of robotic surgery.

ERCP surgery is carried out under X-rays, so the physicians need to wear a 30-pound protective lead apron. They are suffering health risks from long-term radiation exposure and heavy lead weight. In addition, the variable orientation and opening position of the duodenal papilla requires a high level of guide wire operation and the doctors’ cooperation with the assistant. Therefore, the training of a qualified ERCP doctor and an excellent ERCP team requires the accumulation of operating time and experience. These can be easily resolved by surgical robots. In robot-assisted ERCP surgery, the physician can perform the operation remotely behind the wall, away from X-ray exposure. Furthermore, the natural stability, accuracy, and flexibility of robots can effectively reduce the learning curve of ERCP surgery and bring a better outcome to patients.

The natural orifice ERCP flexible surgical robot from Shanghai Operation Robot has a modular design, which imitates the physician working with an assistant. Its small footprint enables easy and flexible movement in the operating room. The robot adopts the principle of master-slave operation, the operation of the master stick is exactly the same as that of traditional manual operation, which greatly shortens the learning time. By operating the left and right master stick together, the physician can manipulate the knob of the endoscope handle, the forceps lifter, the water and gas button, the water absorption button, the guide wire and catheter delivery, withdrawal, and instrument exchange. The robot also includes a closed-loop mechanism for the delivery of the guide wire and instrument, which avoids the risk of slippage or blockage during the movement of the guide wire and instrument. The resistance is reproduced in real-time during the master operation, so the physician possesses the actual feeling.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”